LAK细胞于1985年首次用于晚期癌症的治疗,至今在我国已广泛用于临床癌症患者的免疫治疗,治疗剂型有10ml以内安瓿型和150ml左右液体溶液型,临床上多采用肌肉注射或静脉输注两种形式的全身治疗,并取得了一定的疗效,近年来国内外学者在LAK细胞的临床实践中,有一些新的认识,报告如 LAK cells for the first time in 1985 for the treatment of advanced cancer, so far in our country has been widely used in clinical cancer patients with immunotherapy, the therapeutic dosage form within 10ml ampoule and 150ml liquid solution type, the clinical use of intramuscular or intravenous Note the two forms of systemic treatment, and achieved a certain effect, in recent years, domestic and foreign scholars in the clinical practice of LAK cells, there are some new knowledge, reports such as